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Diabetes mellitus type1 (T1DM) is characterized by 
the appearance of insulitis and the presence of β-
cell autoantibodies1. Emerging evidence indicates 
that immune cell infiltrates comprised 
predominantly of CD8 and CD4 T cells, B cells, 
and macrophages are present in islets from newly 
diagnosed patients, implicating both innate and 
adaptive immune systems in the pro-inflammatory 
process leading to islet cell death2 . 
Cytokines have been reported to be involved in 
the immunopathology of several autoimmune 
diseases including type 1 diabetes .There is 
evidence that cytokines could have a direct role in 
β-cell death3 . 
Interleukin-12 p40 production influences T cell 
response, and may therefore be important in T1DM 
pathogenesis. Interleukin-12 (IL-12) drives the 
differentiation of T lymphocytes towards the Th1 
subset, characterized by production of cytokines 
leading to cell mediated immunity. In addition, IL-
12 is important in immune response to infections; 
however, it has been shown that in absence of 
infection, IL-12 induced autoreactive T cell 
responses might predispose to self-destructive 
immunity4. 
The significance of IL-12 in human 
autoimmunity is not clear, and serum levels of IL-
12 in diabetes mellitus have not been well 
established. Elevated levels of this cytokine have 
been observed in most autoimmune diseases.5,6 
 
METHODS 
The study population consisted of 50 patients with 
type 1 diabetes mellitus (mean age, 9.19±3.3 years) 
recruited from the outpatient endocrinology clinic, 
Zagazig University Hospitals, during the period 
from August 2011 to September 2012. In addition, 
30 age and sex matched healthy children (mean age, 
8.7±3.8 years) with no family history of diabetes 
served as a control group. 
 
Exclusion criteria: the study excluded patients with 
signs of chronic inflammatory, neoplastic, allergic 
or other autoimmune diseases, in addition to 
patients receiving immunomodulatory drugs. 
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Methodology: Diabetic children were residing in 
the vicinity of the Zagazig University Hospital and 
were treated with a standard dose of human insulin 
obtained from Novo Nordisk Industry, Copenhagen, 
Denmark. All patients were taking 2 to 4 
subcutaneous insulin doses per day.  
All children were subjected to: Full history taking 
to ensure the diagnosis of type 1 diabetes and reveal 
family history of the disease, thorough physical 
examination, routine laboratory investigations:  
complete blood count (CBC), random blood sugar, 
HBA1C (glycated hemoglobin) and serum IL-12 
levels were assessed by ELISA. 
 
Measuring HbA1c: Whole blood samples were 
assessed for Glycated HB level with a micro-
chromatographic procedure for the quantitation of 
glycosylated hemoglobin Glyco Hb Quick Column 
procedure (Helana).  
 
Detection in Serum of IL-12 Levels: Serum 
samples were collected and stored at -4°C for the 
quantitative assessment of IL-12 using enzyme-
linked immunosorbent assay (ELISA) technique 
(AviBion Human IL-12 EASIA kit). Samples were 
brought to room temperature and processed 
according to manufacturer’s description. Colour 
detection was read at 450 nm Correcting for optical 
imperfections was done at 630 nm. A standard 
curve was plotted and results were calculated. 
 
Statistical analysis 
All data were analyzed using the Statistical Package 
for Social Science (SPSS) 14 for Windows. All data 
were presented as mean ± standard deviation (SD). 
Chi-square test (χ2) was used to compare 
differences between the frequencies. Serum 
cytokines levels were analyzed using the normality 
test. Student t test was used to compare mean 
values between groups. Comparing several means 
was done by one-way analysis of variance 
(ANOVA) .Spearman rank correlation test was used 
for the assessment of correlation. The statistical 
significance was accepted as p value < 0.05.  
 
RESULTS 
The demographic and clinical data of the 
studied groups are enlisted in table 1.  Table 2 
shows levels of HbA1c, IL12, random blood sugar 
(RBS), and hematological parameters. Statistical 
analysis of the studied parameters in relation to 
Body Mass Index (BMI) are illustrated in tables 3. 
According to HbA1c levels, 12 patients only had 
good diabetic control, while 24 had poor control.  
Significant differences in IL12 levels are noted in 
relation to glycosylated hemoglobin levels (Table 
4). IL12 levels were significantly higher in the 
recently diagnosed patients as demonstrated in table 
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Table 2.  Laboratoy data of the studied groups. 
 
 Diabetic children Control t P 
WBcs ×103/cm 8.3 ± 3.7 5.5 ± 1.5 2.18 < 0.01* 
HB g/dl 12.2 ± 0.9 12.15 ± 0.97 0.31 0.6 
HbA1c(%) 9.47 ± 1.9 
6.14 – 12.7 
5.6 ± 0.36 
5.1 – 6.2 
10.8 < 0.001* 
IL12 (pg/ml) 23.4 ± 10.79 
10 – 56 
6.2 ± 2.5 
2 – 11 
8.4 < 0.001* 
RBS mg/dl 268.7 ± 95 
116 – 466 
87.9 ± 12.1 
70 – 112 
10.3 < 0.001* 
*Significant ;  IL-12: interleukin 12; RBS: random blood sugar; WBcs: white 
blood cells; Hb: hemoglobin; HbA1c:   glycated hemoglobin. 
 
 
Table 3. Statistical analysis of laboratory parameters in patients according to Body Mass Index (BMI) 
 
 Underweight diabetics 
(n = 6) 
BMI<5th percentile 
Lean diabetics 
(n = 36) 
BMI 5th-94th percentile 
Obese diabetics 
(n = 8) 
BMI ≥ 95th percentile 
F p 
IL-12 (pg/ml) 23.6±7.9 21.0±5.8 33.8±8.3 5.2 0.008*
HbA1c (%)  8.7 ± 2.0 9.2 ± 1.87 11.0±1.4 3.63 0.03
* 
RBS mg/dl 233.3 ± 72.9 255.6 ± 81.1 354.2±86.3 4.54 0.015*
WBCs ×103/cm 8.35 ± 2.8 8.6 ± 2.5 8.2±2.3 0.2 0.81 
*Significant ;  IL-12: interleukin 12; RBS: random blood sugar; WBcs: white blood cells; HbA1c:   glycated hemoglobin. 
 
 




(n = 12) 
HbA1c 6-7.9% 
Fair  control 
(n = 14) 
HbA1c 8-9.9% 
Poor control 
(n = 24) 
HbA1c ≥10% 
F P 
IL-12 pg/ml 16.8±6.6 22.4±7.1 27.3±7.7 4.1 0.02* 
WBCs 103/cm 8.0±1.02 8.4±2.5 8.7±2.3 0.22 0.8 
RBS mg/dl 141.3±19 247.9±25 344.5±64.1 79.9 <0.001* 
BMI kg/m2 20.76±2.3 21.8±2.98 22.1±3.3 0.79 0.45 
*Significant ;  IL-12: interleukin 12; RBS: random blood sugar; WBcs: white blood cells; BMI: 
body mass index. 
 
 




(n = 23) 
1-3 years 
(n = 18) 
> 3 years
(n = 9) 
F P 
IL-12 (pg/ml) 31.46±9 17.6±4.9 14.4±3.6 21.8 < 0.001* 
WBcs  ×103 9.2±2.1 8±1.2 6.4±1.9 3.95 < 0.025* 
RBS mg/dL 298.3±87 256.1±80.1 218.2±57 2.69 0.07 
HbA1c % 10.1±1.7 9.1±1.9 8.4±1.89 3.36 0.051 
*Significant ;  IL-12: interleukin 12; RBS: random blood sugar; WBcs: white 
blood cells; HbA1c: glycated hemoglobin. 
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The present study showed a highly significant 
increase in IL-12 level in diabetics (23.4±10.79 
pg/ml.) as compared to healthy children (6.2±2.5 
pg/ml). The same was reported by other researchers 
7,8 . Blazhev et al.9 proved that elevated IL-12 
plasma levels were detected in both types of 
diabetes (T1DM: X±SE, pg/ml = 2.4±0.16, T2DM: 
2.35±0.10, p < 0.01) as compared to healthy control 
subjects (1.86±0.07).  Sarsvik et al.10 suggested that 
IL-12 plays a critical role in the pathogenesis of 
type 1 diabetes as it affects a variety of stages in the 
immune response: it prompts NK cells and T cells 
to produce pro-inflammatory cytokines, as 
Interferon-γ (IFN-γ), IL-2, IL-3 and TNF-α; it 
contributes to NK cell maturation, and it stimulates 
CD4-CD25 T cell activation. IL-12 also regulates 
naive T cell differentiation into T-helper type 1 
lymphocytes (Th1), and inhibits differentiation into 
T-helper type 2 lymphocytes (Th2)
 11. 
However, the precise mechanisms by which 
IL-12 could induce pathological damage in 
diabetics have not been completely clarified. The 
elevated levels of circulating IL-12 are associated 
with the activity or severity of various autoimmune 
diseases 12.  In patients with active multiple sclerosis 
(MS), serum levels of IL-12 are detectable in 53%, 
whereas none of the patients with clinically inactive 
MS has detectable IL-12. Moreover, IL-12 levels 
correlate well with the degree of inflammation in 
cerebrospinal fluid. In patients with rheumatoid 
arthritis (RA), levels of IL-12 are elevated in serum 
and synovial fluids with a direct correlation with 
disease activity12.  
Our results showed high production of IL-
12p40 in patients with T1DM. Gattorno et al.
13 
proved the elevation of IL-12 in juvenile chronic 
arthritis, psoriasis, as well as in experimental 
models of diabetes. In agreement with an earlier 
study14, our data revealed that there was no 
significant difference in IL-12 level in relation to 
gender in diabetic cases. Also we did not find 
significant difference between diabetic males and 
females with respect to HbA1c, CBC, BMI and 
RBS. 
The study revealed a significant variation in 
IL-12 levels according to BMI in diabetics , as IL-
12 levels were higher in overweight subjects 
(33.8±8.3 pg/ml) when compared with under and 
normal weight ones (23.6±7.9 pg/ml and 21 ± 5.8 
pg/ml  respectively). Increased levels of cytokines 
were reported in overweight patients with type 1 
diabetes.15 These findings can be explained by a 
proinflammatory effect of childhood obesity 8,9. 
Similarly, the study showed a significant 
increase in HbA1c in over weight (11.0±1.4) versus 
lower level in lean (9.2±1.87) and underweight 
(8.7±2.0) diabetics. A previous study concluded 
that obesity and insulin resistance take part in the 
pathogenesis of type 1 diabetes in children and 
adolescents and said that over weight patients with 
type 1 diabetes had significantly higher HbA1c15.  
In agreement with Wu et al.16, lower levels  of 
IL-12 were  noted  in patients  with good metabolic 
control (HbA1c%,6-7.9%) than in  patients  with 
fair control (HbA1c%,8-9.9) and poor control 
(HbA1c% ≥ 10) with p<0.05. IL-12 and other 
proinflammatory cytokines were reported to 
increase by hyperglycemia in subjects with 
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impaired glucose tolerance 17. The highly significant 
correlation between IL-12 levels and HbA1c 
[r=0.42; p<0.001] which was consistent with a 
previous study18 implies that the proinflamatory 
effect of IL12 may have a crucial role in the 
severity and control of T1DM. 
In the present study and in a previous work 19, 
newly diagnosed patients with T1DM of less than 
one year duration had significantly higher levels of 
IL-12 when compared to diabetic patient with 
duration more than one year. However; these results 
were inconsistent with those of Miteva et al.20. 
In conclusion, type 1 diabetes is associated 
with elevation of IL-12 levels. This association is 
more evident in both newly diagnosed and poorly 
controlled patients indicating a relevant role of IL-
12 on the pathogenesis of the disease. 
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